These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 24079855)
1. Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study. Johnsen E; Sinkeviciute I; Løberg EM; Kroken RA; Hugdahl K; Jørgensen HA BMC Psychiatry; 2013 Sep; 13():241. PubMed ID: 24079855 [TBL] [Abstract][Full Text] [Related]
2. Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial. Kjelby E; Jørgensen HA; Kroken RA; Løberg EM; Johnsen E BMC Psychiatry; 2011 Aug; 11():145. PubMed ID: 21884578 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. Johnsen E; Kroken RA; Wentzel-Larsen T; Jørgensen HA BMC Psychiatry; 2010 Mar; 10():26. PubMed ID: 20334680 [TBL] [Abstract][Full Text] [Related]
4. Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial. Johnsen E; Jørgensen HA; Kroken RA; Løberg EM Eur Psychiatry; 2013 Mar; 28(3):174-84. PubMed ID: 22153730 [TBL] [Abstract][Full Text] [Related]
5. One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis. San L; Arranz B; Perez V; Safont G; Corripio I; Ramirez N; Dueñas R; Alvarez E Psychiatry Res; 2012 Dec; 200(2-3):693-701. PubMed ID: 22954905 [TBL] [Abstract][Full Text] [Related]
6. Quetiapine versus other atypical antipsychotics for schizophrenia. Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315 [TBL] [Abstract][Full Text] [Related]
7. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial. Lublin H; Haug HJ; Koponen H; Sigmundsson T; Kolb SA World J Biol Psychiatry; 2009; 10(4 Pt 3):710-8. PubMed ID: 18803070 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Rosenheck RA; Perkins DO; Keefe RS; Davis CE; Severe J; Hsiao JK; Am J Psychiatry; 2006 Apr; 163(4):611-22. PubMed ID: 16585435 [TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia. Olfson M; Gerhard T; Huang C; Lieberman JA; Bobo WV; Crystal S Schizophr Bull; 2012 Jun; 38(4):845-53. PubMed ID: 21307041 [TBL] [Abstract][Full Text] [Related]
10. Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone. Gómez-Revuelta M; Pelayo-Terán JM; Juncal-Ruiz M; Vázquez-Bourgon J; Suárez-Pinilla P; Romero-Jiménez R; Setién Suero E; Ayesa-Arriola R; Crespo-Facorro B Int J Neuropsychopharmacol; 2020 Apr; 23(4):217-229. PubMed ID: 31974576 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. McEvoy JP; Lieberman JA; Stroup TS; Davis SM; Meltzer HY; Rosenheck RA; Swartz MS; Perkins DO; Keefe RS; Davis CE; Severe J; Hsiao JK; Am J Psychiatry; 2006 Apr; 163(4):600-10. PubMed ID: 16585434 [TBL] [Abstract][Full Text] [Related]
12. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. Jing Y; Kim E; You M; Pikalov A; Tran QV J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. McEvoy JP; Lieberman JA; Perkins DO; Hamer RM; Gu H; Lazarus A; Sweitzer D; Olexy C; Weiden P; Strakowski SD Am J Psychiatry; 2007 Jul; 164(7):1050-60. PubMed ID: 17606657 [TBL] [Abstract][Full Text] [Related]
14. Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials. Stauffer V; Ascher-Svanum H; Liu L; Ball T; Conley R BMC Psychiatry; 2009 Mar; 9():13. PubMed ID: 19335905 [TBL] [Abstract][Full Text] [Related]
15. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. Jin H; Shih PA; Golshan S; Mudaliar S; Henry R; Glorioso DK; Arndt S; Kraemer HC; Jeste DV J Clin Psychiatry; 2013 Jan; 74(1):10-8. PubMed ID: 23218100 [TBL] [Abstract][Full Text] [Related]
16. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial. Kilian R; Steinert T; Schepp W; Weiser P; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Längle G Eur Arch Psychiatry Clin Neurosci; 2012 Oct; 262(7):589-98. PubMed ID: 22526729 [TBL] [Abstract][Full Text] [Related]
18. Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia. Garman PM; Ried LD; Bengtson MA; Hsu C; McConkey JR J Am Pharm Assoc (2003); 2007; 47(3):373-8. PubMed ID: 17510032 [TBL] [Abstract][Full Text] [Related]
19. A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). Stroup TS; McEvoy JP; Ring KD; Hamer RH; LaVange LM; Swartz MS; Rosenheck RA; Perkins DO; Nussbaum AM; Lieberman JA; Am J Psychiatry; 2011 Sep; 168(9):947-56. PubMed ID: 21768610 [TBL] [Abstract][Full Text] [Related]
20. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial. Sacchetti E; Valsecchi P; Parrinello G; Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]